The company's approved ANDA is therapeutically equivalent to AstraZeneca Pharmaceuticals's Brilinta Tablets, 60 mg and 90 mg, it added.

Lorundrostat effectively reduced 24-hour blood pressure in patients with well-treated, uncontrolled hypertension in the phase ...

The use of lemborexant vs placebo is effective and well-tolerated to treat sleep symptoms among patients with insomnia.

Adult and pediatric generalized myasthenia gravis patients have a new, longer acting option for treatment called Imaavy.

The company has predicted that Imaavy — now approved for myasthenia gravis — could eventually earn more than $5 billion in ...

The FDA has approved a monoclonal antibody to treat individuals aged 12 years and older with generalized myasthenia gravis ...

The FDA approved nipocalimab (Imaavy) injection to treat adults and children ages 12 and older with generalized myasthenia ...

While Johnson & Johnson isn't the first to secure FDA approval for an FcRn-blocking antibody in myasthenia gravis, the New ...

Detailed price information for Xortx Therapeutics Inc (XRTX-X) from The Globe and Mail including charting and trades.

tremors and movement — for a longer period of time for patients who were also taking at least 400 mg of levodopa a day and were experiencing "motor fluctuations," which are periods of time when ...

Spotted in Malaysia earlier this week, the MG S5 has now been previewed ahead of its launch. The electric C-segment SUV replaces the underwhelming ZS EV and takes the fight to the Proton eMas 7 ...

If PRX-115 can achieve similar uric acid control with fewer immune complications, the drug could compete very well with KRYSTEXXA. But investors should be aware that this is all speculative as the ...